Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ARGX argenex	$660.00 -0.6%	$593.54	$510.05 ▼ $696.21	$40.39B	0.39	374,162 shs	222,887 shs
GSK GSK	$40.15 +0.2%	$38.35	$31.72 ▼ $44.67	$81.80B	0.51	5.16 million shs	3.40 million shs
TAK Takeda Pharmaceutical	$15.50 +1.3%	$14.80	$12.80 ▼ $15.56	$49.33B	0.22	2.56 million shs	3.46 million shs
TEVA Teva Pharmaceutical Industries	$18.47 -1.8%	$16.72	$12.47 ▼ $22.80	$21.18B	0.62	12.20 million shs	13.29 million shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ARGX argenex	+0.42%	+1.73%	+16.19%	+12.95%	+26.30%
GSK GSK	-0.03%	+2.17%	+8.22%	+3.49%	-4.31%
TAK Takeda Pharmaceutical	-1.16%	+3.32%	+5.08%	+4.94%	+2.38%
TEVA Teva Pharmaceutical Industries	+6.80%	+7.06%	+15.32%	+10.90%	+3.65%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ARGX argenex	3.9034 of 5 stars	3.6	2.0	0.0	2.9	1.7	3.1
GSK GSK	2.9094 of 5 stars	0.9	5.0	2.5	4.0	0.0	2.5
TAK Takeda Pharmaceutical	1.5558 of 5 stars	0.0	3.0	2.5	3.3	0.0	0.6
TEVA Teva Pharmaceutical Industries	3.9034 of 5 stars	3.6	4.0	0.8	3.6	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ARGX argenex	3.10	Buy	$746.81	12.89% Upside
GSK GSK	1.88	Reduce	$37.38	-6.97% Downside
TAK Takeda Pharmaceutical	3.00	Buy	N/A	N/A
TEVA Teva Pharmaceutical Industries	3.25	Buy	$24.71	34.06% Upside

Current Analyst Ratings Breakdown

Latest TEVA, GSK, TAK, and ARGX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/4/2025	ARGX argenex	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$775.00 ➝ $830.00
8/1/2025	ARGX argenex	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$700.00 ➝ $766.00
8/1/2025	ARGX argenex	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$1,060.00 ➝ $1,070.00
8/1/2025	ARGX argenex	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$720.00 ➝ $774.00
7/31/2025	ARGX argenex	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$741.00 ➝ $756.00
7/21/2025	ARGX argenex	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform	$715.00
7/8/2025	ARGX argenex	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy
7/3/2025	ARGX argenex	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$700.00
7/1/2025	ARGX argenex	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$720.00
6/26/2025	TEVA Teva Pharmaceutical Industries	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$24.00 ➝ $23.00
6/24/2025	ARGX argenex	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$715.00

(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ARGX argenex	$3.05B	13.26	$2.97 per share	222.51	$99.60 per share	6.64
GSK GSK	$31.63B	2.59	$5.60 per share	7.18	$9.41 per share	4.27
TAK Takeda Pharmaceutical	$30.09B	1.64	$3.18 per share	4.87	$14.89 per share	1.04
TEVA Teva Pharmaceutical Industries	$16.63B	1.27	$3.52 per share	5.23	$5.96 per share	3.09

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ARGX argenex	$833.04M	$19.50	33.86	60.97	0.76	40.98%	21.06%	18.25%	10/30/2025 (Estimated)
GSK GSK	$3.29B	$2.16	18.59	8.64	1.74	10.81%	49.22%	11.31%	10/29/2025 (Estimated)
TAK Takeda Pharmaceutical	$712.33M	$0.30	51.65	9.39	N/A	3.20%	10.50%	5.10%	10/30/2025 (Estimated)
TEVA Teva Pharmaceutical Industries	-$1.64B	-$0.16	N/A	7.01	1.04	-0.95%	46.10%	7.18%	11/5/2025 (Estimated)

Latest TEVA, GSK, TAK, and ARGX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/31/2025	Q2 2025	ARGX argenex	$2.84	$3.74	+$0.90	$3.74	$776.82 million	$866.79 million
7/30/2025	Q2 2025	GSK GSK	$1.12	$1.23	+$0.11	$0.94	$7.92 billion	$10.64 billion
7/30/2025	Q1 2026	TAK Takeda Pharmaceutical	$0.47	$0.52	+$0.05	$0.27	$7.96 billion	$7.45 billion
7/30/2025	Q2 2025	TEVA Teva Pharmaceutical Industries	$0.64	$0.66	+$0.02	$0.24	$4.34 billion	$4.18 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ARGX argenex	N/A	N/A	N/A	N/A	N/A
GSK GSK	$1.68	4.18%	N/A	77.78%	N/A
TAK Takeda Pharmaceutical	$0.55	3.55%	N/A	183.33%	N/A
TEVA Teva Pharmaceutical Industries	$1.01	5.48%	N/A	N/A	N/A

Latest TEVA, GSK, TAK, and ARGX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/31/2025	GSK GSK	quarterly	$0.4206	4.3%	8/15/2025	8/15/2025	10/9/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ARGX argenex	N/A	5.60	5.27
GSK GSK	1.07	0.87	0.57
TAK Takeda Pharmaceutical	0.60	1.16	0.59
TEVA Teva Pharmaceutical Industries	2.45	1.06	0.77

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ARGX argenex	60.32%
GSK GSK	15.74%
TAK Takeda Pharmaceutical	9.17%
TEVA Teva Pharmaceutical Industries	54.05%

Insider Ownership

Company	Insider Ownership
ARGX argenex	2.43%
GSK GSK	10.00%
TAK Takeda Pharmaceutical	0.04%
TEVA Teva Pharmaceutical Industries	0.49%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ARGX argenex	1,599	61.20 million	59.71 million	Optionable
GSK GSK	68,629	2.04 billion	1.83 billion	Optionable
TAK Takeda Pharmaceutical	47,455	3.18 billion	3.18 billion	Optionable
TEVA Teva Pharmaceutical Industries	36,830	1.15 billion	1.14 billion	Optionable

TEVA, GSK, TAK, and ARGX Headlines

Recent News About These Companies

Teva Pharmaceutical: Tariff Relief Clears The Way For Reinvention

3 hours ago | seekingalpha.com

Banco BTG Pactual S.A. Has $571,000 Position in Teva Pharmaceutical Industries Ltd. $TEVA

August 22 at 7:10 AM | marketbeat.com

Northwest & Ethical Investments L.P. Has $548,000 Stock Position in Teva Pharmaceutical Industries Ltd. $TEVA

August 22 at 4:43 AM | marketbeat.com

Aberdeen Group plc Acquires 286,206 Shares of Teva Pharmaceutical Industries Ltd. $TEVA

August 21 at 4:18 AM | marketbeat.com

State of New Jersey Common Pension Fund D Buys 41,300 Shares of Teva Pharmaceutical Industries Ltd. $TEVA

August 20 at 6:04 AM | marketbeat.com

Billionaire Stanley Druckenmiller Sold All of His Palantir and Has Piled Into This High-Flying Drug Stock for 4 Consecutive Quarters

August 20 at 3:51 AM | fool.com

Fjarde AP Fonden Fourth Swedish National Pension Fund Has $4.49 Million Stock Holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)

August 19 at 5:01 AM | marketbeat.com

Teva Pharmaceutical Industries Ltd. $TEVA Shares Sold by National Bank of Canada FI

August 19 at 4:15 AM | marketbeat.com

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Holdings Lifted by Menora Mivtachim Holdings LTD.